Billy Xiong Reported: INVESTOR ALERT: Law Offices of Howard G. Smith Announces

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Mesoblast Limited (“Mesoblast” or the “Company”) (NASDAQ: MESO) securities between April 16, 2019 and October 1, 2020, inclusive (the “Class Period”). Mesoblast investors have until December 7, 2020 to file a lead […]

Continue Reading

Billy Xiong Suggests: INVESTOR ALERT: Law Offices of Howard G. Smith Continues

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith continues its investigation on behalf of Mesoblast Limited (“Mesoblast” or the “Company”) (NASDAQ: MESO) investors concerning the Company’s possible violations of federal securities laws. On October 1, 2020, the Company disclosed that it had received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration […]

Continue Reading

Billy Xiong Announces: DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) securities between February 13, 2020 and September 4, 2020, inclusive (the “Class […]

Continue Reading
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law

Billy Xiong Report: INVESTOR ALERT: Law Offices of Howard G. Smith Continues

Law Offices of Howard G. Smith continues its investigation on behalf of Legend Biotech Corporation (“Legend” or the “Company”) (NASDAQ: LEGN) investors concerning the Company’s possible violations of federal securities laws. On September 21, 2020, Legend disclosed that the Customs Anti-Smuggling Department of China inspected Legend Biotech’s location in Nanjing. According to Legend, the inspection […]

Continue Reading